A total of 135 KMT2A rearrangements have been described in leukemias, mostly resulting in KMT2A-fusion proteins capable of transforming hematopoietic stem cells into leukemic blasts with stem cell-like properties (72, 75–78). Here, KMT2A is linked to leukemia.